A recent study published in CLINICAL CANCER RESEARCH suggests that the protein hVps37A suppresses tumour growth in ovarian cancer. The work, which was funded by the Austrian Science Fund FWF, shows, for the first time, that this protein is significantly reduced in ovarian cancer cells.
The scientists also found that this reduction affects a cellular signalling pathway that is associated with the membrane receptor EGFR (Epidermal Growth Factor Receptor). The receptor is considered an important biological marker for the course of the disease and therapy, and also serves as a target for modern treatment of different cancer types. In fact, the cells in which hVps37A synthesis was reduced showed resistance to Cetuximab, an approved substance for inhibition of EGFR activity.
The hVps37A gene as such is not unknown to scientists. In the period 2004 to 2007, a systematic genome search as part of a project funded by the Austrian Science Fund FWF determined that, among others, this gene is down-regulated in ovarian cancer. The then head of studies, Prof. Michael Krainer, has now studied the function of this gene further in this particular type of cancer. The published results of this follow-up project show that hVps37A is a hitherto unknown tumour suppressor gene.
The Epidermal Growth Factor Receptor (EGFR) "transmits" signals from the extracellular domain to within the cell. The binding of signal substances on the cell surface of the receptor causes a chemical modification (phosphorylation) of the receptor structure on the side of the cell lumen. This signal subsequently affects numerous cellular processes significantly, including cell proliferation, and may therefore contribute to the development of cancer.EFFECTIVE DEGRADATION
This theory would explain another result found by Prof. Krainer´s group, namely that cancer cells with reduced hVps37A activity become resistant to Cetuximab, but not to Lapatinib. Cetuximab inhibits EGFR-mediated signal transduction; however, the Cetuximab-EGFR complex must then be degraded in order for the therapy to remain effective. In the case of Lapatinib, which directly inhibits EGFR phosphorylation, this is not necessary.
On the whole, the results from this FWF project offer the first fundamental description of a previously unknown tumour suppressor gene in ovarian cancer cells. Its effect on the EGF receptor also makes the tumour suppressor gene relevant for other types of cancer.
Original Publication: hVps37A Status Affects Prognosis and Cetuximab Sensitivity in Ovarian Cancer. M. Wittinger, P. Vanhara, A. El-Gazzar, B. Savarese-Brenner, D. Pils, M. Anees, T. W. Grunt, M. Sibilia, M. Holcmann, R. Horvat, M. Schemper, R. Zeillinger, C. Schöfer, H. Dolznig, P. Horak and M. Krainer. Clinical Cancer Research 2011;17:7816-7827 DOI:10.1158/1078-0432.CCR-11-0408Picture and text available from Monday, 13 February 2012, 9 am CET at:
Margot Pechtigam | PR&D
Scientists uncover the role of a protein in production & survival of myelin-forming cells
19.07.2018 | Advanced Science Research Center, GC/CUNY
NYSCF researchers develop novel bioengineering technique for personalized bone grafts
18.07.2018 | New York Stem Cell Foundation
A new manufacturing technique uses a process similar to newspaper printing to form smoother and more flexible metals for making ultrafast electronic devices.
The low-cost process, developed by Purdue University researchers, combines tools already used in industry for manufacturing metals on a large scale, but uses...
For the first time ever, scientists have determined the cosmic origin of highest-energy neutrinos. A research group led by IceCube scientist Elisa Resconi, spokesperson of the Collaborative Research Center SFB1258 at the Technical University of Munich (TUM), provides an important piece of evidence that the particles detected by the IceCube neutrino telescope at the South Pole originate from a galaxy four billion light-years away from Earth.
To rule out other origins with certainty, the team led by neutrino physicist Elisa Resconi from the Technical University of Munich and multi-wavelength...
For the first time a team of researchers have discovered two different phases of magnetic skyrmions in a single material. Physicists of the Technical Universities of Munich and Dresden and the University of Cologne can now better study and understand the properties of these magnetic structures, which are important for both basic research and applications.
Whirlpools are an everyday experience in a bath tub: When the water is drained a circular vortex is formed. Typically, such whirls are rather stable. Similar...
Physicists working with Roland Wester at the University of Innsbruck have investigated if and how chemical reactions can be influenced by targeted vibrational excitation of the reactants. They were able to demonstrate that excitation with a laser beam does not affect the efficiency of a chemical exchange reaction and that the excited molecular group acts only as a spectator in the reaction.
A frequently used reaction in organic chemistry is nucleophilic substitution. It plays, for example, an important role in in the synthesis of new chemical...
Optical spectroscopy allows investigating the energy structure and dynamic properties of complex quantum systems. Researchers from the University of Würzburg present two new approaches of coherent two-dimensional spectroscopy.
"Put an excitation into the system and observe how it evolves." According to physicist Professor Tobias Brixner, this is the credo of optical spectroscopy....
13.07.2018 | Event News
12.07.2018 | Event News
03.07.2018 | Event News
20.07.2018 | Materials Sciences
20.07.2018 | Physics and Astronomy
20.07.2018 | Materials Sciences